These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11370497)

  • 21. [Conservative treatment with chemotherapy and radiotherapy in bladder cancer invading the muscle: preliminary results of a prospective study].
    Zapatero A; Pinar B; Arellano R; López M; Marín A; Jiménez U; Pérez Torrubia A
    Arch Esp Urol; 1997 Jun; 50(5):448-54; discussion 454-6. PubMed ID: 9382586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can bladder preservation therapy come to the center stage?
    Inamoto T; Ibuki N; Komura K; Juri H; Yamamoto K; Yamamoto K; Fujita K; Nonomura N; Narumi Y; Azuma H
    Int J Urol; 2018 Feb; 25(2):134-140. PubMed ID: 29171098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bladder preservation multimodality therapy as an alternative to radical cystectomy for treatment of muscle invasive bladder cancer.
    Maarouf AM; Khalil S; Salem EA; ElAdl M; Nawar N; Zaiton F
    BJU Int; 2011 May; 107(10):1605-10. PubMed ID: 20825396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Future therapies for the treatment of bladder neoplasms.
    See WA; Berman CJ
    Semin Surg Oncol; 1997; 13(5):376-88. PubMed ID: 9259094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evolving concepts in muscle-invasive bladder cancer.
    Black PC; Kassouf W
    World J Urol; 2016 Jan; 34(1):1-2. PubMed ID: 26743671
    [No Abstract]   [Full Text] [Related]  

  • 26. Is there a role for bladder preserving strategies in the treatment of muscle-invasive bladder cancer?
    Kuczyk M; Turkeri L; Hammerer P; Ravery V;
    Eur Urol; 2003 Jul; 44(1):57-64. PubMed ID: 12814676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of high-risk, non-muscle-invasive bladder cancer.
    Lerner SP
    Nat Clin Pract Urol; 2006 Aug; 3(8):398-9. PubMed ID: 16902498
    [No Abstract]   [Full Text] [Related]  

  • 28. Adjuvant Therapy in Muscle-Invasive Bladder Cancer and Upper Tract Urothelial Carcinoma.
    Achkar T; Parikh RA
    Urol Clin North Am; 2018 May; 45(2):257-266. PubMed ID: 29650141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. De novo muscle invasive bladder cancer: is there a change in trend?
    Vaidya A; Soloway MS; Hawke C; Tiguert R; Civantos F
    J Urol; 2001 Jan; 165(1):47-50; discussion 50. PubMed ID: 11125361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Superficial TCC bladder cancer: the impact of tumor differentiation on recurrence, progression and survival.
    Kurth KH
    Prog Clin Biol Res; 1984; 162A():307-18. PubMed ID: 6483914
    [No Abstract]   [Full Text] [Related]  

  • 31. Delayed local recurrence following radiation therapy for muscle-invasive bladder cancer emphasizing the need for lifelong surveillance: a case report.
    Sunkara R; Ayyathurai R; Nieder A; Manoharan M
    ScientificWorldJournal; 2008 Feb; 8():166-8. PubMed ID: 18301817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [pT1G3 tumor of the bladder].
    Vicini D; Bettaglio G; Dallera P; Ruggieri M; Mirando P; Franceschetti GP; Sali C; Picchio GL
    Arch Ital Urol Androl; 1996 Feb; 68(1):61-5. PubMed ID: 8664925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of regionally advanced bladder cancer. An overview.
    Droller MJ
    Urol Clin North Am; 1992 Nov; 19(4):685-93. PubMed ID: 1441025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The case for neoadjuvant chemotherapy and cystectomy for muscle invasive bladder cancer.
    deVere White RW; Katz MH; Steinberg GD
    J Urol; 2009 May; 181(5):1994-7. PubMed ID: 19286209
    [No Abstract]   [Full Text] [Related]  

  • 35. Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic review.
    Ploussard G; Daneshmand S; Efstathiou JA; Herr HW; James ND; Rödel CM; Shariat SF; Shipley WU; Sternberg CN; Thalmann GN; Kassouf W
    Eur Urol; 2014 Jul; 66(1):120-37. PubMed ID: 24613684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymphovascular invasion and the presence of more than three tumors are associated with poor outcomes of muscle-invasive bladder cancer after bladder-conserving therapies.
    Zhang M; Tao R; Zhang C; Shen Z
    Urology; 2010 Oct; 76(4):902-7. PubMed ID: 20709377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bladder tumours in children.
    Beurton D; Magnier M; Cukier J
    Prog Clin Biol Res; 1984; 162B():289-301. PubMed ID: 6390449
    [No Abstract]   [Full Text] [Related]  

  • 38. A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer.
    Freiha F; Reese J; Torti FM
    J Urol; 1996 Feb; 155(2):495-9; discussion 499-500. PubMed ID: 8558644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic strategies for organ-confined and non-organ-confined bladder cancer after radical cystectomy.
    Marchioni M; Nazzani S; Preisser F; Bandini M; Karakiewicz PI
    Expert Rev Anticancer Ther; 2018 Apr; 18(4):377-387. PubMed ID: 29429376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [T1G3 bladder tumors: 5 years later].
    Pegoraro C; Bondovalli C; Dall'Oglio B; Schiavon L; Luciano M; Parma A
    Arch Ital Urol Androl; 1996 Feb; 68(1):35-8. PubMed ID: 8664919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.